Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127434331 | 12743433 | 1 | I | 20160822 | 20160905 | 20160914 | 20160914 | EXP | ITA-AIFA 373355 | IT-VALIDUS PHARMACEUTICALS LLC-IT-2016VAL002638 | VALIDUS | 87.00 | YR | M | Y | 0.00000 | 20160914 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127434331 | 12743433 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 50 MG, QD | 29800 | MG | Y | 16273 | 50 | MG | |||||
| 127434331 | 12743433 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | TABLET | ||||||
| 127434331 | 12743433 | 3 | SS | LUVION | CANRENONE | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | TABLET | ||||||
| 127434331 | 12743433 | 4 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | U | 0 | ||||||||||
| 127434331 | 12743433 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | U | 0 | ||||||||||
| 127434331 | 12743433 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 127434331 | 12743433 | 7 | C | LORAZEPAM. | LORAZEPAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 127434331 | 12743433 | 8 | C | PAROXETINE. | PAROXETINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127434331 | 12743433 | 1 | Hypertension |
| 127434331 | 12743433 | 2 | Hypertension |
| 127434331 | 12743433 | 3 | Hypertension |
| 127434331 | 12743433 | 4 | Product used for unknown indication |
| 127434331 | 12743433 | 5 | Product used for unknown indication |
| 127434331 | 12743433 | 6 | Product used for unknown indication |
| 127434331 | 12743433 | 7 | Product used for unknown indication |
| 127434331 | 12743433 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127434331 | 12743433 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127434331 | 12743433 | Acute kidney injury | |
| 127434331 | 12743433 | Drug interaction | |
| 127434331 | 12743433 | Hyperkalaemia | |
| 127434331 | 12743433 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127434331 | 12743433 | 1 | 20150105 | 20160822 | 0 | |
| 127434331 | 12743433 | 4 | 20120101 | 20160825 | 0 | |
| 127434331 | 12743433 | 5 | 20120101 | 20160825 | 0 | |
| 127434331 | 12743433 | 6 | 20150105 | 20160825 | 0 | |
| 127434331 | 12743433 | 8 | 20160811 | 20160825 | 0 |